Outcome of Board Meeting
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.2 pts more than Nifty Microcap 250 and 7.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Camlin Fine Sciences Ltd reported FY26 standalone revenue of Rs 8,379.2 lakh (down 5.5% from Rs 8,865 lakh in FY25) and a standalone loss before tax of Rs 541 lakh. On a consolidated basis, revenue grew 5.8% to Rs 17,233 lakh from Rs 16,287 lakh. Key exceptional items included Rs 222 lakh impact from new Labour Codes, Rs 266 lakh impairment of trade receivables from liquidated CFS Europe SpA, Rs 763 lakh loss from a fire incident at CFS Do Brasil, and Rs 406 lakh Vinpai acquisition costs. CFS Europe SpA was placed under liquidation in March 2026, generating a Rs 1,029 lakh gain on derecognition. Auditors issued unmodified (clean) opinions. The Board appointed Mr. Pankaj Pandey as CFO effective August 18, 2026, with Mr. Santosh Parab re-designated to President - Strategy and Global CFO.
The standalone revenue decline combined with operating losses signals continued challenges in the domestic business, though the Vinpai acquisition boosted consolidated revenue. The clean audit opinion provides some comfort, but shareholders should monitor the turnaround in standalone operations and integration of recent acquisitions.